ZYN and the FDA's first pouch authorisation

ZYN is made by the Swedish company Swedish Match. Philip Morris International bought Swedish Match in 2022.

The FDA decision

On 16 January 2025 the US Food and Drug Administration authorised 20 ZYN products for sale to US adults aged 21 and over. They were the first nicotine pouches the FDA had authorised. The FDA said that authorisation was not an approval and did not mean the products were safe. The authorisation covers those US products only, not the ZYN range sold elsewhere.

The range

The ZYN we stock is the European range, and strengths vary by flavour. The ZYN collection shows each flavour with its strength.

New to pouches? Our guide What is a nicotine pouch? covers the basics.

Pouches contain nicotine, which is addictive, and they're for adults who already use nicotine.

Sources

• US FDA, "FDA Authorizes Marketing of 20 ZYN Nicotine Pouch Products after Extensive Scientific Review", 16 January 2025 (fda.gov): the authorisation, its date, the age limit of 21, that it is "the first time the agency has authorized products commonly referred to as nicotine pouches", and that it does not mean the products are safe or "FDA approved".
• Business Wire, Philip Morris Holland Holdings release on completing its offer for Swedish Match, 27 November 2022, and NACS, "PMI Moves Forward With Swedish Match Purchase", 8 November 2022: Philip Morris International's purchase of Swedish Match, the maker of ZYN, in 2022.